SCHEMBL17436331

SCHEMBL17436331

N#Cc1cccc(F)c1-c1cnc(Cl)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 7/20 0.41
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GABRA1 P14867 3/20 0.39
GABRG2 P18507 3/20 0.39
GABRB3 P28472 3/20 0.39
GABRA5 P31644 3/20 0.39
GABRA3 P34903 3/20 0.39
PDE4B Q07343 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
CYP11B1 P15538 4/20 0.37
PIN1 Q13526 2/20 0.37
BCAT1 P54687 1/20 0.37
HIF1A Q16665 1/20 0.37
GABRA2 P47869 1/20 0.36
CNR2 P34972 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983241 0.75 PRMT5 (0.40) CYP11B2GABRA1GABRG2GABRB3GABRA5
SCHEMBL19557545 0.74 EGLN2 (0.44) CYP11B2GABRA1GABRG2GABRB3GABRA5
SCHEMBL15999122 0.74 HIF1A (0.47) ALDH1A1GABRA1GABRG2GABRB3GABRA5
SCHEMBL29912400 0.73 CLK4 (0.41) CYP11B2ALDH1A1NPSR1GABRA1GABRG2
SCHEMBL17436061 0.73 ESR2 (0.50) ALDH1A1NPSR1TDP1GABRA1GABRG2
SCHEMBL1586204 0.73 CLK4 (0.41) CYP11B2ALDH1A1NPSR1GABRA1GABRG2
SCHEMBL24084229 0.71 PDK2 (0.43) CYP11B2ALDH1A1GABRA1GABRG2GABRB3
SCHEMBL22730146 0.71 CYP11B2 (0.40) CYP11B2GABRA1GABRG2GABRB3GABRA5
SCHEMBL17436140 0.71 SYK (0.45) TDP1PIN1GRIN1GRIN2B
SCHEMBL23753823 0.71 PIK3CD (0.47) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074812-B Substituted pyrimidine compounds 格吕伦塔尔有限公司 2020-08-21 CN disclosed
EP-3527561-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2019-08-21 EP disclosed
US-10189854-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2019-01-29 US disclosed
EP-3169681-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2017-05-24 EP disclosed
US-20170066776-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-03-09 US disclosed
US-9540349-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-01-10 US disclosed
US-20160016937-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2016-01-21 US disclosed
WO-2016008593-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189854-B2 Substituted pyrimidine compounds TYMP, PDE4A, DPYD CYP11B2 276/4885ALDH1A1 353/4885NPSR1 2309/4885
US-20160016937-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP CYP11B2 173/4885ALDH1A1 443/4885NPSR1 2203/4885
US-20170066776-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP CYP11B2 173/4885ALDH1A1 443/4885NPSR1 2203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.